Evidence map›Paper›PMID 40435502›Full record

ArticleJMIR research protocols2025

Barriers and Facilitators to HIV and Viral Hepatitis Testing in Primary Health Care Settings in the Kyrgyz Republic (BarTest): Protocol for a Mixed Methods Study.

Ida Sperle, Nikolay Lunchenkov, Zuridin S Nurmatov, Aybek A Bekbolotov, Anastassiya Stepanovich-Falke, Michael Brandl, Olena Kysil, Stela Bivol, Viviane Bremer, Barbara Gunsenheimer-Bartmeyer and 1 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ida SperleDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0002-8024-582X
Nikolay LunchenkovDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0001-8567-9240
Zuridin S NurmatovNational Institute of Public Health of the Ministry of Health, Bishkek, Kyrgyzstan.ORCID 0000-0003-3481-227X
Aybek A BekbolotovNational Institute of Public Health of the Ministry of Health, Bishkek, Kyrgyzstan.ORCID 0000-0001-9931-3311
Anastassiya Stepanovich-FalkeDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-0113-189X
Michael BrandlDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-2820-5019
Olena KysilDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0002-1408-0422
Stela BivolWorld Health Organization, Regional Office for Europe, Copenhagen, Denmark.ORCID 0000-0002-4711-9100
Viviane BremerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-0158-7053
Barbara Gunsenheimer-BartmeyerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0001-6126-7786
Sandra DudarevaDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-1803-704X

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIn the Kyrgyz Republic, it is estimated that 18% of people living with HIV are undiagnosed and more than half are diagnosed late (CD4 lymphocyte count of <350 cells/μL). For viral hepatitis, before 2023, free testing was only available to people living with HIV, which led to a low testing uptake. A new national program on the elimination of HIV and viral hepatitis infection for the years 2023-2027 recognizes the need to scale up testing to reduce the gap in undiagnosed people in the country.

objectiveThis study aimed to identify and describe the most important barriers and facilitators to HIV and viral hepatitis B, C, and D testing from the perspective of health care workers working in primary health care settings in the Kyrgyz Republic.

methodsA cross-sectional, mixed methods study was conducted in 2 phases. A purposive sampling approach was applied to recruit health care workers in primary health care settings. In phase I, in-depth, semistructured interviews were conducted with 22 participants to gather detailed information about the key barriers and facilitators for testing. We applied a thematic approach for qualitative analysis. The themes identified informed the development of a questionnaire with the main barriers and facilitators for phase II. The questionnaire was distributed electronically, and the target sample size was 400 participants. We performed descriptive analyses of the questionnaire data, reporting the most frequently mentioned barriers and facilitators for HIV and viral hepatitis testing.

resultsThe study received financial support in the framework of the Global Health Protection Programme by the Federal Government of Germany. Data collection took place in June 2024 for phase I and in November 2024 for phase II. Data analyses and writing up of results will be done in early 2025 and results are expected to be published in spring 2025.

conclusionsThe results of the study will improve the understanding of existing barriers and facilitators to HIV and viral hepatitis testing in order to increase testing offers and uptake in primary health care settings in the Kyrgyz Republic. Importantly, the findings will inform steps to improve the implementation of the new testing strategy and, ultimately, increase the number of people diagnosed and treated in the Kyrgyz Republic. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/62929.

Indexed as

Hepatitis, Viral, HumanHIV InfectionsMass ScreeningPrimary Health CareAdultCross-Sectional StudiesFemaleHealth PersonnelHumansKyrgyzstanMaleQualitative Researchbarriershealth care workersHIVKyrgyz Republicprimary health caretestingviral hepatitis

Identifiers

PMID40435502
PMCPMC12159551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.